Pricing pressure in a key cancer drug, coupled with a steep rise in March shipments to the US ahead of potential tariffs, has ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...

After more than a decade of digital transformation, pharmaceutical marketing is on the cusp of achieving what the industry ...

Amphastar has signed an exclusive license agreement with Anji for the development, production, use and commercialisation of 3 ...

The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...

What Happened: MD's decision to sell 11,659 shares of Collegium Pharmaceutical was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total value of the sale ...

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...

The court was deciding on an anticipatory bail plea moved by Vicky Ramancha, who has been accused of criminal conspiracy and ...

We do not support the formation, amendment, or implementation of any committee that excludes industry entrepreneurs. With the upcoming LDC graduation in mind, the right decisions must be taken to ...

Our editorial team dives into the pharma industry's reaction to US tariffs on imports from the European Union and major trends from Q2 earnings calls.

For years, India has quietly carried a global responsibility that most people outside the health sector barely notice — we ...

The plan targets consolidated revenues of $371mln, a 131% increase compared to 2023/2024, and net profits of $70mln - up 343% ...